Poland· PL-100502595
Klimadynon
A cimicifugae rhizoma product containing cimicifugae racemosae rhizomae extractum siccum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Cimicifugae rhizoma is registered in 7 of 19 countries.
Countries holding a registration under ATC G02CX04 (cimicifugae rhizoma), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Cimicifugae rhizoma · ATC G02CX04
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Cimicifugae racemosae rhizomae extractum siccum
- Manufacturer
- InPharm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- G02CX04
- ATC class
- Cimicifugae rhizoma
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991552428
- gtin05909991552435
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cimicifugae rhizoma in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBestmade Natural Products Cimicifuga RacemosaBestmade Natural Products
- NetherlandsCimicifuga racemosaHeel Belgium n.v.
- FinlandCimicifuga
- CzechiaMENOFEMBionorica SE, Neumarkt
- SpainMENSIFEM COMPRIMIDOS RECUBIERTOS CON PELICULABionorica Se
- FranceMENSIFEM, comprimé pelliculéBIONORICA (ALLEMAGNE)
- NorwayRemifeminSchaper & Brümmer GmbH & Co KG
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Belgium · Donnafyta Meno
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/db08dfbc-4489-42ed-90d6-f35435e226ec GET /v1/drugs/db08dfbc-4489-42ed-90d6-f35435e226ec?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "2,8 mg",
"packaging": "05909991552428 ¦ OTC ¦ 157560\n60 tabl.\n05909991552435 ¦ OTC ¦ 157561\n90 tabl.",
"substance": "Cimicifugae racemosae extractum siccum 2.8 mg",
"common_name": "Cimicifugae racemosae rhizomae extractum siccum",
"pl_product_id": "100502595",
"pozwolenie_nr": "318/24",
"auth_procedure": "IR",
"authorisation_validity": "2029-08-07"
}See everything about cimicifugae rhizoma.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.